Halsey Drug and Watson Labs fenoprofen calcium ANDAs
Both generic firms received ANDA approvals for fenoprofen calcium 200 mg and 300 mg capsules, and for 600 mg tablets. The July 18 issue of "The Pink Sheet" (T&G-13) incorrectly listed the 600 mg tablets as capsules. Halsey's approval is dated July 5, and Watson Labs' is dated July 8, both ANDA approvals have the delayed effective date of Aug. 17, 1988.
You may also be interested in...
A “structured dialog” led by the European Commission with pharmaceutical industry stakeholders provides a critical opportunity to address weaknesses in the stability and security of the supply chain by improving the environment for local manufacturing, Medicines for Europe believes.
Despite a slight increase in revenue, South Africa’s Adcock continues to struggle as it reports a continued drop in gross profit. The company expects the economy to remained constrained due to COVID-19, but is eagerly anticipating recovery with the government’s vaccine roll-out.
Round-up of the latest news across EMEA, including two deals for Bayer in Egypt and Saudi Arabia; Orkla's acquisition of NutraQ; and Uriach's deal for Sidroga.